News

Climedo Health partners with BMG in the fight against COVID-19

EIT Health Headstart Award 2020 winner Climedo Health secures a contract with the BMG until the end of 2021

As part of the containment of the COVID-19 pandemic, EIT Health launched a special Headstart programme for COVID-19 solutions in May 2020. the idea was to give digital health start-ups the opportunity to relieve the health system with their solutions. The team from Climedo Health was able to convince the jury with its digital symptom diary for automated contact person tracking can do exactly this. In the face of the pandemic, Climedo Health made its digital platform available to institutions free of charge in order to help speed up the efforts against the virus and the start-up was later named as “Heroes in the Crisis” for its outstanding commitment in these times. As a Headstart winner, Climedo Health received a grant of € 50,000 to further develop the solution. Now the Munich-based software company has announced its collaboration with the Federal Ministry of Health (BMG).

The digital symptom diary gathers the disease progression of COVID-19 patients as well as suspected cases and can therefore rapidly track down the chain of infection. The daily inquiry by the health authorities about the patients’ state of health now belongs to the past: health status data is collected and contributes to a holistic, cost-effective and safe way of recording and monitoring COVID-19 cases. The application is completely in line with the aim of the BMG to enable nationwide, secure, and fast electronic reporting and information processing in regard to positive SARS-CoV2 pathogen detection.

The product is already being used successfully by public health authorities throughout Germany, saving employees up to 80% of the time in contact person tracking. Affected persons automatically receive a standardised online questionnaire with a link to document their state of health every day via email or text message.  The completed questionnaire can then be viewed immediately by the responsible health department. Assignment and recording take place automatically. The collected data is pseudonymised and used by research institutes as well as doctors to document the patient’s condition.

The development of the digital symptom diary took place in close coordination with the BMG, the Robert Koch Institute (RKI) as well as with the involvement of the Federal Office for Information Security (BSI), the Federal Commissioner for Data Protection and Freedom of Information (BfDI) and the Academy of Public Health Services.

On 10 November 2020, the symptom diary was presented at the Dialog ÖGD digital meeting with Health Minister Jens Spahn. The live stream dialogue and demo can be accessed here  (German only).

The application has been in test mode operation since May 2020 […] and is currently in use in almost 20 health authorities in more than 8 German federal states and has recently been used by all interested health authorities at no additional cost thanks to the BMG, states Sascha Ritz, CEO of Climedo Health.